Daily Archives: August 4, 2015

A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

Posted on August 4, 2015 by Simeon Springer, Yuxuan Wang, Marco Dal Molin, David L. Masica, Yuchen Jiao, Isaac Kinde, Amanda Blackford, Siva P. Raman, Christopher L. Wolfgang, Tyler Tomita, Noushin Niknafs, Christopher Douville, Janine Ptak, Lisa Dobbyn, Peter J. Allen, David S

The management of pancreatic cysts poses challenges to both patients and their physicians. We investigated whether a combination of molecular markers and clinical information could improve the classification of pancreatic cysts and management of patients. Continue reading →

Posted in News | Comments Off on A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

Posted on August 4, 2015 by Simeon Springer, Yuxuan Wang, Marco Dal Molin, David L. Masica, Yuchen Jiao, Isaac Kinde, Amanda Blackford, Siva P. Raman, Christopher L. Wolfgang, Tyler Tomita, Noushin Niknafs, Christopher Douville, Janine Ptak, Lisa Dobbyn, Peter J. Allen, David S

The management of pancreatic cysts poses challenges to both patients and their physicians. We investigated whether a combination of molecular markers and clinical information could improve the classification of pancreatic cysts and management of patients. Continue reading →

Posted in News | Comments Off on A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

Posted on August 4, 2015 by Frank van Hees, Sameer D. Saini, Iris Lansdorp-Vogelaar, Sandeep Vijan, Reinier G. Meester, Harry J. de Koning, Ann G. Zauber, Marjolein van Ballegooijen

Colorectal cancer (CRC) screening decisions for elderly individuals are often made based primarily on age—other factors that affect the effectiveness and cost effectiveness of screening are often not considered. We investigated the relative importanc… Continue reading →

Posted in News | Comments Off on Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

Posted on August 4, 2015 by Frank van Hees, Sameer D. Saini, Iris Lansdorp-Vogelaar, Sandeep Vijan, Reinier G. Meester, Harry J. de Koning, Ann G. Zauber, Marjolein van Ballegooijen

Colorectal cancer (CRC) screening decisions for elderly individuals are often made based primarily on age—other factors that affect the effectiveness and cost effectiveness of screening are often not considered. We investigated the relative importanc… Continue reading →

Posted in News | Comments Off on Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

Extreme Bradycardia After First Doses of Sofosbuvir and Daclatasvir in Patients Receiving Amiodarone: 2 Cases Including a Rechallenge

Posted on August 4, 2015 by Sophie Renet, Marie-Camille Chaumais, Teresa Antonini, Alexandre Zhao, Laure Thomas, Arnaud Savoure, Didier Samuel, Jean-Charles Duclos-Vallée, Vincent Algalarrondo

Sofosbuvir and daclatasvir are direct-acting antiviral drugs used to treat chronic hepatitis C virus infection. In 2015, the Food and Drug Administration and European Medical Agency warned that bradycardia could occur when amiodarone was administered i… Continue reading →

Posted in News | Comments Off on Extreme Bradycardia After First Doses of Sofosbuvir and Daclatasvir in Patients Receiving Amiodarone: 2 Cases Including a Rechallenge

Extreme Bradycardia After First Doses of Sofosbuvir and Daclatasvir in Patients Receiving Amiodarone: 2 Cases Including a Rechallenge

Posted on August 4, 2015 by Sophie Renet, Marie-Camille Chaumais, Teresa Antonini, Alexandre Zhao, Laure Thomas, Arnaud Savoure, Didier Samuel, Jean-Charles Duclos-Vallée, Vincent Algalarrondo

Sofosbuvir and daclatasvir are direct-acting antiviral drugs used to treat chronic hepatitis C virus infection. In 2015, the Food and Drug Administration and European Medical Agency warned that bradycardia could occur when amiodarone was administered i… Continue reading →

Posted in News | Comments Off on Extreme Bradycardia After First Doses of Sofosbuvir and Daclatasvir in Patients Receiving Amiodarone: 2 Cases Including a Rechallenge